Understanding lymphoma: Get the facts at a free virtual education event on Sept. 28

Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

To highlight September as Lymphoma Awareness Month, Natasha Edwin, M.D., hematologist, medical oncologist at Providence Cancer Institute in partnership with Asian Health & Service Center shares the latest information about lymphoma and the types, risk factors, symptoms, diagnosis, staging, treatments and side effects.

Learn more about virtual educational talks and other community events.  

About Dr. Natasha Edwin

Dr. Natasha Edwin is a hematologist and medical oncologist at Providence Oncology and Hematology Care Clinic - Westside and specializes in the treatment of patients with blood cancer and blood disorders.

Dr. Edwin is passionate about putting her patients at ease by personalizing treatments, aligning them with their own values, and empowering them with the knowledge they need to make informed decisions about their care. She is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Edwin is a strong proponent of participation in clinical trials. She has served on the Leukemia Committee of the Eastern Cooperative Oncology Group and on the Board of Directors for the Alliance for Clinical trials in Oncology.

Experienced care for patients with cancer and blood disorders 

The Providence Hematologic Malignancies Program provides compassionate care for cancers of the blood, bone marrow and lymph nodes. We combine the most advanced therapies with new research to use your body's own immune system to fight cancer.

Our team of physicians are experts in hematologic malignancies including Hodgkin and non-Hodgkin lymphomas, leukemia, multiple myeloma and the myelodysplastic syndromes. We use a team approach to care because we know you’ll benefit most when you have the knowledge of many different specialists guiding your treatment. Learn more.

Related news

Multi-indication clinical trials help evaluate new medications for future treatments

Study to evaluate effect of immunotherapy in blood cancer

 

11/23/2022
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
11/7/2022
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
10/6/2022
Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.
10/19/2022
Leading lung cancer professionals to gather in November for premier oncology summit.